MedPath

PROSTIN

Prostin VR Pediatric alprostadil injection, USP

Approved
Approval ID

930f8c02-46a8-4cff-a484-660468ab23c3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 3, 2022

Manufacturers
FDA

Pharmacia & Upjohn Company LLC

DUNS: 618054084

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

alprostadil

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0009-0215
Application NumberNDA018484
Product Classification
M
Marketing Category
C73594
G
Generic Name
alprostadil
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAVASCULAR
Effective DateOctober 3, 2022
FDA Product Classification

INGREDIENTS (2)

ALPROSTADILActive
Quantity: 500 ug in 1 mL
Code: F5TD010360
Classification: ACTIB
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PROSTIN - FDA Drug Approval Details